Showing results (91-100 of 110) with videos related to
Sort By:
Pageof 11
Cancers|November 27, 2024
Molecular and In Silico Analysis of the <i>CHEK2</i> Gene in Individuals with High Risk of Cancer Predisposition from TürkiyeOzkan Ozdemir, Brittany L Bychkovsky, Busra Unal, et al.Journal of Clinical Pathology|January 27, 2016
Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemiaEda Tanrikulu Simsek, Ahmet Emre Eskazan, Mahir Cengiz, et al.International Journal of Laboratory Hematology|April 12, 2021
Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemiaYucel Erbilgin, Ozden Hatirnaz Ng, Ismail Can, et al.Leukemia Research|August 5, 2011
Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemiaSinem Firtina, Muge Sayitoglu, Ozden Hatirnaz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countriesAnnie O Chan, Amr S Soliman, Qing Zhang, et al.Clinical Lymphoma, Myeloma & Leukemia|August 30, 2017
Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and GlivecAhmet Emre Eskazan, Sevil Sadri, Dilek Keskin, et al.Immunologic Research|October 7, 2021
Primary antibody deficiencies in Turkey: molecular and clinical aspectsSinem Firtina, Yuk Yin Ng, Ozden H Ng, et al.International Journal of Immunogenetics|May 24, 2020
Mutational landscape of severe combined immunodeficiency patients from TurkeySinem Firtina, Yuk Yin Ng, Ozden Hatirnaz Ng, et al.Blood|March 7, 2009
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet StudyMichele Baccarani, Gianantonio Rosti, Fausto Castagnetti, et al.Scientific Reports|March 12, 2021
Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidatesGozde Sir Karakus, Cihan Tastan, Derya Dilek Kancagi, et al.Pageof 11